Speclipse

Speclipse is the world's first developer of medical diagnostic devices based on Laser-Induced Plasma Spectroscopy (LIPS) and Artificial Intelligence (AI) technology. Our core product, spectrum-scope®, enables real-time, non-invasive, in-vivo skin cancer diagnosis, preventing unnecessary biopsies without compromising efficacy and accuracy. The company’s laser spectroscopy technology overcomes the limitations of existing blood analysis methods, as it can simultaneously detect minute differences in various blood biomarkers. Speclipse also leverages AI and deep learning to process and analyze vast amounts of blood spectroscopy data, enabling early diagnosis of stomach cancer and Alzheimer’s disease.